Renaud Du Pasquier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


211 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | ...
2024
 
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Callegari I., Oechtering J., Schneider M., Perriot S., Mathias A., Voortman M.M., Cagol A., Lanner U., Diebold M., Holdermann S. et al., 2024/03/01. Brain, 147 (3) pp. 839-848. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D17D7B26D32]
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
Oechtering J., Stein K., Schaedelin S.A., Maceski A.M., Orleth A., Meier S., Willemse E., Qureshi F., Heijnen I., Regeniter A. et al., 2024/03. Neurology, 11 (2) pp. e200212. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8A3AEC81CECB]
 
Neurologie: ce qui a changé en 2023 [Neurology: what's new in 2023]
Pizzarotti B., Buhler-Heintze A., Allali G., Rouaud O., Bally J., Michel P., Hirt L., Théaudin M., Pot Kreis C., Ryvlin P. et al., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 72-75. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_288F00E19F37]
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A., Benkert P., Melie-Garcia L., Schaedelin S.A., Leber S., Tsagkas C., Barakovic M., Galbusera R., Lu P.J., Weigel M. et al., 2024/01/09. Neurology, 102 (1) pp. e207768. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83EF6BE319F6]
2023
 
Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles.
Oberholster L., Mathias A., Perriot S., Blaser E., Canales M., Jones S., Culebras L., Gimenez M., Kaynor G.C., Sapozhnik A. et al., 2023/12/12. Microbiology spectrum, 11 (6) pp. e0275123. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E6A065E798E]
 
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Abdelhak A., Benkert P., Schaedelin S., Boscardin W.J., Cordano C., Oechtering J., Ananth K., Granziera C., Melie-Garcia L., Montes S.C. et al., 2023/12/01. JAMA neurology, 80 (12) pp. 1317-1325. Peer-reviewed.
[DOI][Pmid][serval:BIB_8ADA992C8122]
 
The Swiss Brain Health Plan 2023–2033
Bassetti Claudio L. A., Heldner Mirjam R., Adorjan Kristina, Albanese Emiliano, Allali Gilles, Arnold Marcel, Bègue Indrit, Bochud Murielle, Chan Andrew, do Cuénod Kim Q. et al., 2023/11/13. Clinical and Translational Neuroscience, 7 (4) p. 38.
[DOI][serval:BIB_CBDD6C3797BA]
 
SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
Stüdle C., Nishihara H., Wischnewski S., Kulsvehagen L., Perriot S., Ishikawa H., Schroten H., Frank S., Deigendesch N., Du Pasquier R. et al., 2023/10/24. Fluids and barriers of the CNS, 20 (1) p. 76. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89002C22D715]
 
Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
Born T., Vassallo P., Golshayan D., Di Liberto G., Brouland J.P., Egervari K., Merkler D., Du Pasquier R.A., Bernard-Valnet R., 2023/09/26. Neurology, 101 (13) pp. e1382-e1386. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5F359B44943]
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Todea A.R., Melie-Garcia L., Barakovic M., Cagol A., Rahmanzadeh R., Galbusera R., Lu P.J., Weigel M., Ruberte E., Radue E.W. et al., 2023/09. Journal of magnetic resonance imaging, 58 (3) pp. 864-876. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC74FD68A743]
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P., Damas J., Viala B., Assal F., Nawej Tshikung O., Tarr P., Derfuss T., Oberholzer M., Jelcic I., Hundsberger T. et al., 2023/07/01. Journal of acquired immune deficiency syndromes, 93 (3) pp. 219-228. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_369AC239E3C3]
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A5312D01C4F]
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
Damas J., Darling KEA, Bidlingmeyer P., Nadin-Debluë I., Bieler M., Vollino L., Sokolov A.A., Berney A., Maccaferri G., Filippidis P. et al., 2023/06. HIV medicine, 24 (6) pp. 738-748. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC28428CED42]
 
Troubles cognitifs chez les personnes vivant avec le VIH. L’importance d’une prise en charge multidisciplinaire [Multidisciplinary assessment and management of neurocognitive complaints in people living with HIV]
Damas J., Berney A., Bieler-Aeschlimann M., Cavassini M., Du Pasquier R., 2023/04/26. Revue medicale suisse, 19 (824) pp. 797-799. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A5FA8E8B5103]
 
Troubles cognitifs dans la sclérose en plaques : quand y penser ? [Cognitive impairment in multiple sclerosis: when to think about it?]
Perrenoud M., Blosch L., Du Pasquier R., Pot C., 2023/04/26. Revue medicale suisse, 19 (824) pp. 791-793. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9A05F4407CED]
 
Chapter 6: Neuroinfectious Diseases
Bernard-Valnet Raphael, Du Pasquier Renaud A., 2023/04/18. Neurology, 100 (16) pp. S75-S76.
[DOI][WoS][serval:BIB_385F159CF409]
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D74F62B5F2C9]
Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System.
Perbet R., Zufferey V., Leroux E., Parietti E., Espourteille J., Culebras L., Perriot S., Du Pasquier R., Bégard S., Deramecourt V. et al., 2023/03/23. Cells, 12 (7) p. 985. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C3B822B226C]
 
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study.
Carta S., Cobo Calvo Á., Armangué T., Saiz A., Lechner C., Rostásy K., Breu M., Baumann M., Höftberger R., Ayzenberg I. et al., 2023/03/14. Neurology, 100 (11) pp. e1095-e1108. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F4545BBF6CF6]
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
Mathias A., Pantazou V., Perriot S., Canales M., Jones S., Oberholster L., Moulin M., Fenwick C., Bernard-Valnet R., Théaudin M. et al., 2023/03. Neurology: Neuroimmunology & Neuroinflammation, 10 (2) pp. e200084. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53DB58799AAF]
 
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Meier S., Willemse EAJ, Schaedelin S., Oechtering J., Lorscheider J., Melie-Garcia L., Cagol A., Barakovic M., Galbusera R., Subramaniam S. et al., 2023/03/01. JAMA neurology, 80 (3) pp. 287-297. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A537F5BA3984]
 
Neurologie : ce qui a changé en 2022 [Neurology: what's new in 2022]
Bouvy C., Caranzano L., Allali G., Bally J., Benninger D., Beuchat I., Castro Jimenez M., Di Virgilio G., Hirt L., Michel P. et al., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 42-45. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_16DE2FC29F95]
2022
 
Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
Nishihara H., Perriot S., Gastfriend B.D., Steinfort M., Cibien C., Soldati S., Matsuo K., Guimbal S., Mathias A., Palecek S.P. et al., 2022/12/19. Brain, 145 (12) pp. 4334-4348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA179A32E58A]
Delirium in Adults With COVID-19-Related Acute Respiratory Distress Syndrome: Comparison With Other Etiologies.
Bernard-Valnet R., Favre E., Bernini A., Oddo M., Chiche J.D., Du Pasquier R.A., Rossetti A.O., CORO-NEURO-ICU Study Group, 2022/11/15. Neurology, 99 (20) pp. e2326-e2335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D15D8A00A8C0]
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2022/09/16. STAR protocols, 3 (3) p. 101620. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8C8118CBC867]
 
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B., Scherrer A.U., Darling KEA, Damas J., Bieler-Aeschlimann M., Hasse B., Schlosser L., Hachfeld A., Gutbrod K., Tarr P.E. et al., 2022/09. Open forum infectious diseases, 9 (9) pp. ofac457. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06A5B894B7FF]
Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV.
Di Liberto G., Egervari K., Kreutzfeldt M., Schürch C.M., Hewer E., Wagner I., Du Pasquier R., Merkler D., 2022/08/27. Brain, 145 (8) pp. 2730-2741. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A366732309D6]
 
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A., Schaedelin S., Barakovic M., Benkert P., Todea R.A., Rahmanzadeh R., Galbusera R., Lu P.J., Weigel M., Melie-Garcia L. et al., 2022/07/01. JAMA neurology, 79 (7) pp. 682-692. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77CA7B7F07E5]
 
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis.
Borrelli S., Mathias A., Goff G.L., Pasquier R.D., Théaudin M., Pot C., 2022/07. Multiple sclerosis and related disorders, 63 p. 103887. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_356C04602C66]
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
Santos A., Desgranges F., Jovanovic M., Anichini A., Kritikos A., Dunet V., Brouland J.P., Théaudin M., Pot C., Du Pasquier R. et al., 2022/05. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 49 (3) pp. 445-451. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_971C2088FBE5]
Neurologie [Neurology : what's new in 2021]
Vicino A., Allali G., Bally J., Castro Jimenez M., Chiabotti Salvioni P., Hirt L., Hottinger A., Michel P., Novy J., Pot Kreis C. et al., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 51-55. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A713627E7914]
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
Bernard-Valnet R., Moisset X., Maubeuge N., Lefebvre M., Ouallet J.C., Roumier M., Lebrun-Frenay C., Ciron J., Biotti D., Clavelou P. et al., 2022/01. Neurology, 9 (1) pp. e1097. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C8361307694]
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis.
Singh B., Lant S., Cividini S., Cattrall JWS, Goodwin L.C., Benjamin L., Michael B.D., Khawaja A., Matos AMB, Alkeridy W. et al., 2022. PloS one, 17 (6) pp. e0263595. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE78AFF3D88C]
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_439FE028F29F]
2021
Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined media.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2021/12/17. STAR protocols, 2 (4) p. 100902. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C3E61A00BACB]
Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Bernard-Valnet R., Koralnik I.J., Du Pasquier R., 2021/12. Annals of neurology, 90 (6) pp. 865-873. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5997F734CF2C]
 
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatment.
Pantazou V., Du Pasquier R., Pot C., Le Goff G., Théaudin M., 2021/10. Revue neurologique, 177 (8) pp. 935-940. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D1705A76DD6]
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Maggi P., Kuhle J., Schädelin S., van der Meer F., Weigel M., Galbusera R., Mathias A., Lu P.J., Rahmanzadeh R., Benkert P. et al., 2021/08/10. Neurology, 97 (6) pp. e543-e553. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6A4C8678004D]
Anti-Adenylate Kinase 5 Encephalitis With Histologic Evidence of CNS Vasculitis.
Vicino A., Loser V., Salvioni Chiabotti P., Brouland J.P., Du Pasquier R., 2021/07. Neurology, 8 (4) pp. e1010. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10E3C0EDF2A9]
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
Bernard-Valnet R., Perriot S., Canales M., Pizzarotti B., Caranzano L., Castro-Jiménez M., Epiney J.B., Vijiala S., Salvioni-Chiabotti P., Anichini A. et al., 2021/07. Neurology, 8 (5) pp. e1029. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2403F6DD5AAC]
 
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
Santos G., Locatelli I., Métral M., Berney A., Nadin I., Calmy A., Tarr P., Gutbrod K., Hauser C., Brugger P. et al., 2021/07. International journal of STD & AIDS, 32 (8) pp. 729-739. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_274D6364F028]
 
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment.
Pantazou V., Pot C., Du Pasquier R., Le Goff G., Théaudin M., 2021/06. Multiple sclerosis and related disorders, 51 p. 102918. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F2127C696F5E]
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia.
Borrelli S., Dachy B., Gazagnes M.D., Du Pasquier R., 2021/06. Journal of neurovirology, 27 (3) pp. 510-513. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B1296D9A8376]
Pattern of cognitive deficits in severe COVID-19.
Beaud V., Crottaz-Herbette S., Dunet V., Vaucher J., Bernard-Valnet R., Du Pasquier R., Bart P.A., Clarke S., 2021/05. Journal of neurology, neurosurgery, and psychiatry, 92 (5) pp. 567-568. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F33888332B52]
Neurologie [Recent Advances in Neurology]
Anichini A., Salvioni Chiabotti P., Bally J., Castro Jimenez M., Démonet J.F., Di Virgilio G., Hirt L., Hottinger A., Kuntzer T., Michel P. et al., 2021/01/27. Revue medicale suisse, 17 (723) pp. 196-200. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_66C893415E17]
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
Darling KEA, Locatelli I., Benghalem N., Nadin I., Calmy A., Gutbrod K., Hauser C., Brugger P., Hasse B., Kovari H. et al., 2021. PloS one, 16 (3) pp. e0246579. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1FCA688B6E3]
Case Report: Behavioral Unresponsiveness in Acute COVID-19 Patients: The Utility of the Motor Behavior Tool-Revised and <sup>18</sup>F-FDG PET/CT.
Vijiala S., Epiney J.B., Jöhr J., Pincherle A., Meyer M.M., Du Pasquier R., Prior J.O., Diserens K., 2021. Frontiers in neurology, 12 p. 644848. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E1CE51A4C67E]
 
First-ever treatment in multiple sclerosis.
Pantazou V., Pot C., Du Pasquier R., Le Goff G., Théaudin M., 2021. Revue neurologique, 177 (1-2) pp. 93-99. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4E341AFF275]
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H., Gold R., Berger T., Derfuss T., Linker R., Mäurer M., Aktas O., Baum K., Berghoff M., Bittner S. et al., 2021. Therapeutic advances in neurological disorders, 14 p. 17562864211039648. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4CA9A6A86B8]
2020
Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.
Nishihara H., Gastfriend B.D., Soldati S., Perriot S., Mathias A., Sano Y., Shimizu F., Gosselet F., Kanda T., Palecek S.P. et al., 2020/12. FASEB journal, 34 (12) pp. 16693-16715. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_08BCD9D52C53]
Vaccine-associated measles in a patient treated with natalizumab: a case report
Miauton Alix, Tan Rainer, Pantazou Vasiliki, Du Pasquier Renaud, Genton Blaise, 2020/12. BMC Infectious Diseases, 20 (1) p. 753. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DDD0AF3D357E]
 
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.
Maggi P., Sati P., Nair G., Cortese ICM, Jacobson S., Smith B.R., Nath A., Ohayon J., van Pesch V., Perrotta G. et al., 2020/11. Annals of neurology, 88 (5) pp. 1034-1042. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9DFE2816DFA3]
 
Vaccination in B-cell-depleted patients with multiple sclerosis.
Killestein J., Du Pasquier R., Hemmer B., 2020/10/06. Neurology, 95 (14) pp. 613-614. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD8103AB3E68]
 
Maladies neuro-inflammatoires
Beuchat Isabelle, pantazou vassiliki, du pasquier renaud, 2020/09/22. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
[DOI][serval:BIB_C284315C8FDE]
Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report.
Salvioni Chiabotti P., Bisig B., Cairoli A., Hajdu S.D., Lovey P.Y., Milowich D., Ziadi S., Du Pasquier R., Brouland J.P., de Leval L., 2020/09/14. Frontiers in oncology, 10 p. 1745. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7E269EA64DC]
 
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Blum S., Dunet V., Comoli P., Tirefort Y., Chalandon Y., Opota O., Comte D., Spertini O., Livio F., Brouland J.P. et al., 2020/09. Leukemia & lymphoma, 61 (9) pp. 2226-2229. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13EB95E6B61C]
 
Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.
Bernard-Valnet R., Pizzarotti B., Anichini A., Demars Y., Russo E., Schmidhauser M., Cerutti-Sola J., Rossetti A.O., Du Pasquier R., 2020/09. European journal of neurology, 27 (9) pp. e43-e44. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A29CC9C4F78F]
 
Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque.
Darling K., Métral M., Du Pasquier R., Cavassini M., Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group Swiss HIV Cohort Study, 2020/08. HIV medicine, 21 (7) pp. e19-e20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57111D226B1B]
 
Self-reported Neurocognitive Impairment in People Living With Human Immunodeficiency Virus (HIV): Characterizing Clusters of Patients With Similar Changes in Self-reported Neurocognitive Impairment, 2013-2017, in the Swiss HIV Cohort Study.
Kusejko K., Salazar-Vizcaya L., Braun D.L., Tarr P.E., Bernasconi E., Doco-Lecompte T., Cavassini M., Schmid P., Du Pasquier R., Hauser C. et al., 2020/07/27. Clinical infectious diseases, 71 (3) pp. 637-644. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_04E1F806B33A]
CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis.
Maggi P., Fartaria M.J., Jorge J., La Rosa F., Absinta M., Sati P., Meuli R., Du Pasquier R., Reich D.S., Bach Cuadra M. et al., 2020/05. NMR in biomedicine, 33 (5) pp. e4283. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16E178964567]
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
Metral M., Nadin I., Locatelli I., Tarr P.E., Calmy A., Kovari H., Brugger P., Cusini A., Gutbrod K., Schmid P. et al., 2020/05. HIV medicine, 21 (5) pp. 342-348. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E6AE11286152]
 
Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis Prognosis
Lysandropoulos Andreas P., Perrotta Gaetano, Billiet Thibo, Ribbens Annemie, Du Pasquier Renaud, Pot Caroline, Maggi Pietro, Théaudin Marie, 2020/03. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 47 (2) pp. 189-196.
[DOI][WoS][Pmid][serval:BIB_F1C137EF8B4B]
Evolution of Cortical and White Matter Lesion Load in Early-Stage Multiple Sclerosis: Correlation With Neuroaxonal Damage and Clinical Changes.
Todea R.A., Lu P.J., Fartaria M.J., Bonnier G., Du Pasquier R., Krueger G., Bach Cuadra M., Psychogios M.N., Kappos L., Kuhle J. et al., 2020. Frontiers in neurology, 11 p. 973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_368B9441C688]
RimNet: A deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis.
Barquero G., La Rosa F., Kebiri H., Lu P.J., Rahmanzadeh R., Weigel M., Fartaria M.J., Kober T., Théaudin M., Du Pasquier R. et al., 2020. NeuroImage. Clinical, 28 p. 102412. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_765C195C3334]
The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
Métral M., Darling K., Locatelli I., Nadin I., Santos G., Brugger P., Kovari H., Cusini A., Gutbrod K., Tarr P.E. et al., 2020/01. HIV medicine, 21 (1) pp. 30-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78CE4480FCE1]
2019
 
Pembrolizumab as a treatment for PML? Waiting for Godot.
Du Pasquier R.A., 2019/11. Neurology, 6 (6) pp. e629. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF71C16A1460]
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
Santos GMA, Locatelli I., Métral M., Calmy A., Lecompte T.D., Nadin I., Hauser C., Cusini A., Hasse B., Kovari H. et al., 2019/07. Open forum infectious diseases, 6 (7) pp. ofz277. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_80F1939F32B0]
The (Un)Resolved Case: Blurry vision, left foot drop and brain cysts
Di Liberto G., Aícua-Rapún I., Comps JN, Sherif M., Boillat-Blanco N., Brouland JP, Maeder P., Daniel RT, Du Pasquier RA, Sokolov AA, 2019/07/01. Clinical and Translational Neuroscience, 3 (2) pp. 2514183X1986609.
[URN][DOI][serval:BIB_46C664A370CD]
 
Motor behavior unmasks residual cognition in disorders of consciousness.
Pincherle A., Jöhr J., Chatelle C., Pignat J.M., Du Pasquier R., Ryvlin P., Oddo M., Diserens K., 2019/03. Annals of neurology, 85 (3) pp. 443-447. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F93AB89F71D1]
2018
 
Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines.
Perriot S., Mathias A., Perriard G., Canales M., Jonkmans N., Merienne N., Meunier C., El Kassar L., Perrier A.L., Laplaud D.A. et al., 2018/11/13. Stem cell reports, 11 (5) pp. 1199-1210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9677A578D24]
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T., Martenet S., Mamin R., Du Pasquier R.A., Peters S., Perreau M., Muller O., Hugli O., Cavassini M., Darling KEA, 2018/10/03. BMJ open, 8 (10) pp. e021203. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B109EF61AEB]
 
Late Lyme neuroborreliosis with chronic encephalomyelitis.
Beuchat I., Dunet V., Meylan P., Du Pasquier R., 2018/09/25. Neurology, 91 (13) pp. 627-628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8F2089313695]
Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
Rolf L., Muris A.H., Mathias A., Du Pasquier R., Koneczny I., Disanto G., Kuhle J., Ramagopalan S., Damoiseaux J., Smolders J. et al., 2018/09. Multiple sclerosis, 24 (10) pp. 1280-1287. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD2BEB7A97DB]
 
Mouvements anormaux
Burkhard P., Benninger D., Du Pasquier R., Kleinschmidt A., 2018/04/25. Revue medicale suisse, 14 (604) pp. 867-868. Peer-reviewed.
[Pmid][serval:BIB_C9F343EC417F]
 
Wirksamkeit von Natalizumab bei intermediärer Uveitis bei Multipler Sklerose: ein Fallbericht [Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report]
Roemer S., Bissig A., Rocca A., Du Pasquier R., Guex-Crosier Y., 2018/04. Klinische Monatsblatter fur Augenheilkunde, 235 (4) pp. 476-477. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_95C73E2CFE77]
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.
Hottinger A.F., de Micheli R., Guido V., Karampera A., Hagmann P., Du Pasquier R., 2018/03. Neurology, 5 (2) pp. e439. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_936AFB128A84]
 
Neurologie [Neurology]
Chopard I., Benninger D., Demonet J.F., Du Pasquier R., Hirt L., Kuntzer T., Michel P., Nater B., Novy J., Rossetti A. et al., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 58-61. Peer-reviewed.
[Pmid][serval:BIB_AA0B8A9F29AA]
2017
Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.
Perrotta G., Bonnier G., Meskaldji D.E., Romascano D., Aydarkhanov R., Daducci A., Simioni S., Cavassini M., Metral M., Lazeyras F. et al., 2017/12. Annals of clinical and translational neurology, 4 (12) pp. 915-920. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_73E580433B39]
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.
Mathias A., Perriot S., Canales M., Blatti C., Gaubicher C., Schluep M., Engelhardt B., Du Pasquier R., 2017/11. Neurology: Neuroimmunology & Neuroinflammation, 4 (6) pp. e401. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4147F114C817]
The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
Merienne N., Vachey G., de Longprez L., Meunier C., Zimmer V., Perriard G., Canales M., Mathias A., Herrgott L., Beltraminelli T. et al., 2017/09/19. Cell reports, 20 (12) pp. 2980-2991. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_18C9D3A78F11]
An unusual case of miliary PML-IRIS in an HIV+ patient.
Cuendet D., Sarro R., Merz L., Jiménez M.C., Maeder P., Du Pasquier R., Tsouni P., 2017/07. Neurology(R) neuroimmunology & neuroinflammation, 4 (4) pp. e370. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4E23E384B13E]
 
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Mathias A., Perriard G., Canales M., Soneson C., Delorenzi M., Schluep M., Du Pasquier R.A., 2017/05. Multiple sclerosis, 23 (6) pp. 802-809. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EAF70FDD4B1B]
 
Organisation de la prise en charge des accidents vasculaires cérébraux en Suisse romande
Carrera E., Hirt L., Sztajzel R., Michel P., Kleinschmidt A., Du Pasquier R., 2017/04/26. Revue medicale suisse, 13 (560) pp. 883-884. Peer-reviewed.
[Pmid][serval:BIB_A88DF5599EF5]
 
The Evolution of Cortical and Sub-cortical Lesion Size and Number Correlates with Changes in Cognition in Early-Stage Relapsing-Remitting Multiple Sclerosis Patients
Sorega A., Fartaria MJ., Bonnier G., Kober T., Du Pasquier R., Schluep M., Krueger G., Bach Cuadra M., Granziera C., 2017/04/22. dans Proceedings of 25th Annual Meeting of Intl. Soc. Mag. Reson. Med (ISMRM).
[serval:BIB_DE7A3632558E]
 
Evaluation de la plateforme Neuro-VIH d’un hôpital universitaire par les patients et les médecins traitants [Evaluation of an outpatient multidisciplinary Neuro-HIV clinic by the patients and referring doctors]
Vallotton K., Métral M., Chocron O., Meuli R., Alves D., Du Pasquier R., Cavassini M., 2017/04/12. Revue medicale suisse, 13 (558) pp. 782-786. Peer-reviewed.
[Pmid][serval:BIB_18421788191D]
 
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.
Bacchetta F., Mathias A., Schluep M., Du Pasquier R., 2017/02. Multiple sclerosis, 23 (2) pp. 300-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEF4B976E6D4]
 
Neurologie [Neurology]
Maulucci F., Benninger D., Démonet J.F., Du Pasquier R.A., Hirt L., Hottinger A., Kuntzer T., Michel P., Nater B., Novy J. et al., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 79-83. Peer-reviewed.
[Pmid][serval:BIB_C4707A08C4EF]
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
Clottu A.S., Mathias A., Sailer A.W., Schluep M., Seebach J.D., Du Pasquier R., Pot C., 2017/01/03. Cell reports, 18 (1) pp. 213-224. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C112D80A9534]
 
Stroke management organization in French-speaking Switzerland,Organisation de la prise en charge des accidents vasculaires cérébraux en Suisse romande
Carrera Emmanuel, Hirt Lorenz, Sztajzel Roman, Michel Patrik, Kleinschmidt Andreas, Du Pasquier Renaud, 2017. Revue Medicale Suisse.
[serval:BIB_A31CADC1497B]
The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.
Bonnier G., Maréchal B., Fartaria M.J., Falkowskiy P., Marques J.P., Simioni S., Schluep M., Du Pasquier R., Thiran J.P., Krueger G. et al., 2017. Frontiers in neurology, 8 p. 506. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27FB9942FAEA]
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
Kamal S., Locatelli I., Wandeler G., Sehhat A., Bugnon O., Metral M., Du Pasquier R., Gutbrod K., Cavassini M., Schneider M.P. et al., 2017. Open forum infectious diseases, 4 (2) pp. ofx070. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3B4AA7B205D2]
2016
 
In memoriam Christian Wider, MD 1973-2016.
Ross O.A., Du Pasquier R., 2016/12. Parkinsonism & related disorders, 33 pp. 1-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B5970299A8C4]
 
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.
Marignier R., Durand-Dubief F., du Pasquier R., Vukusic S., 2016/11. Annals of neurology, 80 (5) p. 791. Peer-reviewed.
[DOI][Pmid][serval:BIB_C1FFB5BA2CB1]
 
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Kuhle J., Barro C., Disanto G., Mathias A., Soneson C., Bonnier G., Yaldizli Ö., Regeniter A., Derfuss T., Canales M. et al., 2016/10. Multiple sclerosis, 22 (12) pp. 1550-1559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7771D9B4D9CE]
 
Clinical Reasoning: An 82-year-old woman with dissociated aphasia followed by amnesia.
Eskioglou E., Du Pasquier R.A., Rossetti A.O., Sokolov A.A., 2016/08/30. Neurology, 87 (9) pp. e91-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_63113CB6E8EA]
 
PML risk stratification using anti-JCV antibody index and L-selectin.
Schwab N., Schneider-Hohendorf T., Pignolet B., Spadaro M., Görlich D., Meinl I., Windhagen S., Tackenberg B., Breuer J., Cantó E. et al., 2016/07. Multiple sclerosis, 22 (8) pp. 1048-1060. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47C09F0E3895]
 
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
Fartaria M.J., Bonnier G., Roche A., Kober T., Meuli R., Rotzinger D., Frackowiak R., Schluep M., Du Pasquier R., Thiran J.P. et al., 2016/06. Journal of magnetic resonance imaging, 43 (6) pp. 1445-1454. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C055F759C1ED]
 
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Spatola M., Du Pasquier R., Schluep M., Regeniter A., 2016/05/10. Neurology, 86 (19) pp. 1780-1784. Peer-reviewed.
[DOI][Pmid][serval:BIB_AA34DD001747]
Longitudinal automated detection of white-matter and cortical lesions in relapsing-remitting multiple sclerosis
Fartaria de Oliveira M. J., Bonnier G., Kober T., Roche A., Maréchal B., Rotzinger D., Schluep M., Du Pasquier R., Thiran J. P., Krueger G. et al., 2016/05. dans ISMRM 2016 , ISMRM 24rd Annual Meeting & Exhibition, SMRT 25th Annual Meeting. Peer-reviewed.
[URN][serval:BIB_607576B10BF7]
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
Bonnier G., Kober T., Schluep M., Du Pasquier R., Krueger G., Meuli R., Granziera C., Roche A., 2016. Plos One, 11 (2) pp. e0148631. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9EE5161FAB9]
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Disanto G., Benkert P., Lorscheider J., Mueller S., Vehoff J., Zecca C., Ramseier S., Achtnichts L., Findling O., Nedeltchev K. et al., 2016. Plos One, 11 (3) pp. e0152347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_745A35B87D48]
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Mathias A., Perriard G., Canales M., Vuilleumier F., Perrotta G., Schluep M., Du Pasquier R., 2016. Neurology: Neuroimmunology & Neuroinflammation, 3 (2) pp. e209. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_84CE6387A332]
2015
 
Exploration of advanced MR imaging contrasts for automated detection of white matter and cortical lesions in early-stages of multiple sclerosis
Fartaria Mario Joao, Bonnier Guillaume, Roche Alexis, Kober Tobias, Meuli Reto, Rotzinger David, Schluep Myriam, Du Pasquier Renaud, Thiran Jean-Philippe, Krueger Gunnar et al., 2015/05/30. dans Proceedings of 23th Annual Meeting of ISMRM. Peer-reviewed.
[serval:BIB_FC1DF5F1CBDE]
 
Establishment of a multi-disciplinary platform for HIV-infected patients with neurological complications.
du Pasquier R., Simioni S., Alves D., Meuli R., Maccaferri G.E., Berney A., Cavassini M., 2015/04/08. p. 88 dans Scientific Abstract Listing of the 66th Annual Meeting, , Neurology. Peer-reviewed, American Academy of Neurology (AAN).
[serval:BIB_FDBC807BDBB6]
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
[Pmid][serval:BIB_14E431815FB6]
 
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Derfuss T., Curtin F., Guebelin C., Bridel C., Rasenack M., Matthey A., Du Pasquier R., Schluep M., Desmeules J., Lang A.B. et al., 2015. Multiple Sclerosis, 21 (7) pp. 885-893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C71F817AFA6E]
 
Acute Lyme Neuroborreliosis With Transient Hemiparesis and Aphasia.
Sokolov A.A., Lienhard R., Du Pasquier R., Erard V., 2015. Annals of Emergency Medicine, 66 (1) pp. 60-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AE1D4F0CBA00]
 
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.
Giulieri S., Chapuis-Taillard C., Jaton K., Cometta A., Chuard C., Hugli O., Du Pasquier R., Bille J., Meylan P., Manuel O. et al., 2015. European Journal of Clinical Microbiology and Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 34 (10) pp. 2049-2055. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_16CC808BB9C2]
 
Environmental factors in multiple sclerosis [Environmental factors in multiple sclerosis]
Pantazou V., Schluep M., Du Pasquier R., 2015. Presse Medicale, 44 (4 Pt 2) pp. e113-e120. Peer-reviewed.
[DOI][Pmid][serval:BIB_0E7AB9C32B13]
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Perriard G., Mathias A., Enz L., Canales M., Schluep M., Gentner M., Schaeren-Wiemers N., Du Pasquier R.A., 2015. Journal of Neuroinflammation, 12 p. 119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E0A38EB4D79]
 
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Parfenov V., Du Pasquier R., Schluep M., 2015. Neurologist, 19 (6) pp. 155-157. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7C13D7931E14]
 
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Lalive P.H., Bridel C., Ferfoglia R.I., Kaiser L., Du Pasquier R., Barkhof F., Haller S., 2015. Journal of Neurology, Neurosurgery, and Psychiatry, 86 (3) pp. 354-355. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13E5EDA8BCD2]
 
Multicontrast connectometry: A new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis.
Romascano D., Meskaldji D.E., Bonnier G., Simioni S., Rotzinger D., Lin Y.C., Menegaz G., Roche A., Schluep M., Pasquier R.D. et al., 2015. Human Brain Mapping, 36 (4) pp. 1609-1619. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F441E7B2D6F4]
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Bonnier G., Roche A., Romascano D., Simioni S., Meskaldji D.E., Rotzinger D., Lin Y.C., Menegaz G., Schluep M., Du Pasquier R. et al., 2015. Biomed Research International, 2015 p. 569123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D9EF11DA192]
 
Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
Kurmann R., Weisstanner C., Kardas P., Hirsch H.H., Wiest R., Lämmle B., Furrer H., Du Pasquier R., Bassetti C.L., Sturzenegger M. et al., 2015. Journal of Neurovirology, 21 (6) pp. 694-701. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BECCE3A7DEC0]
 
Relapse in herpes simplex virus encephalitis: It's not just about the virus.
Bale J.F., Du Pasquier R., 2015. Neurology, 85 (20) pp. 1730-1731. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1F9B04EBCBC7]
Status epilepticus of inflammatory etiology: A cohort study.
Spatola M., Novy J., Du Pasquier R., Dalmau J., Rossetti A.O., 2015. Neurology, 85 (5) pp. 464-470. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95C02831E017]
2014
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Bonnier G., Roche A., Romascano D., Simioni S., Meskaldji D., Rotzinger D., Lin Y.C., Menegaz G., Schluep M., Du Pasquier R. et al., 2014/06. Annals of Clinical and Translational Neurology, 1 (6) pp. 423-432. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CA5C2B672057]
 
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Jilek S., Mathias A., Canales M., Lysandropoulos A., Pantaleo G., Schluep M., Du Pasquier R.A., 2014/06. Multiple sclerosis (Houndmills, Basingstoke, England), 20 (7) pp. 837-842. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75F2F83A31AE]
 
Immune system's role in viral encephalitis.
Spatola M., Du Pasquier R.A., 2014. Revue Neurologique, 170 (10) pp. 577-583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_151D4012F1A2]
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.
Du Pasquier R.A., Pinschewer D.D., Merkler D., 2014. Cns Drugs, 28 (6) pp. 535-558. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1AD370581931]
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
Simioni S., Amarù F., Bonnier G., Kober T., Rotzinger D., Du Pasquier R., Schluep M., Meuli R., Sbarbati A., Thiran J.P. et al., 2014. Journal of Neurology, 261 (8) pp. 1606-1613.
[URN][DOI][WoS][Pmid][serval:BIB_CE6349BF43EC]
 
Multicontrats MRI Improved the Clinico-Radiological Correlation in Early Multiple Sclerosis Patients with Minor Deficits
Bonnier Guillaume, Roche Alexis, Romascano David, Simioni Samanta, Meskaldji Djalel Eddine, Rotzinger David, Lin Ying-Chia, Menegaz Gloria, Schluep Myriam, Du Pasquier Renaud et al., 2014. dans 22nd annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM).
[serval:BIB_13F2D0FD73AC]
 
Multiple Sclerosis Lesion Fingerprint Using Multicontrast MRI
Bonnier Guillaume, Roche Alexis, Romascano David, Simioni Samanta, Meskaldji Djalel Eddine, Rotzinger David, Lin Ying-Chia, Menegaz Gloria, Schluep Myriam, Du Pasquier Renaud et al., 2014. dans 22nd annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM).
[serval:BIB_5C5324AFB13F]
 
Neurologie [News in neurology 2013].
Spatola M., Rossetti A.O., Michel P., Kuntzer T., Benninger D., Nater B., Démonet J.F., Schluep M., Du Pasquier R.A., Vingerhoets F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 78-81. Peer-reviewed.
[Pmid][serval:BIB_4D7730CB34C5]
 
Réplication cérébrale du VIH malgré une thérapie antirétrovirale efficace: impact clinique et prise en charge [Intracerebral HIV replication despite an efficient antiretroviral treatment: clinical impact and management].
Schibler M., Calmy A., Cavassini M., Du Pasquier R., 2014. Revue Médicale Suisse, 10 (427) pp. 908, 910-908, 912. Peer-reviewed.
[Pmid][serval:BIB_C6E40680F9A5]
2013
 
A light in the cognitive fog?
Cavassini M., Du Pasquier R.A., 2013. Antiviral Therapy, 18 (2) pp. 149-151. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0C311769084]
 
Anticorps antineuronaux: un domaine en plein développement [Anti-neuronal antibodies: a rapidly developing field].
Zekeridou A., Rossetti A.O., Hottinger A.F., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 909-914.
[Pmid][serval:BIB_50B33579B2CE]
 
Assessing risks of multiple sclerosis therapies.
Parfenov V., Schluep M., Du Pasquier R., 2013. Journal of the Neurological Sciences, 332 (1-2) pp. 59-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F31492A65D5]
 
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
Zahednasab H., 2013. Neurology, 81 (1) pp. 97-98.
[DOI][WoS][Pmid][serval:BIB_B64568DCC059]
 
Maladies auto-immunes neuromusculaires: diagnostic et prise en charge [Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management].
Lalive P.H., Du Pasquier R.A., Chizzolini C., Kuntzer T., 2013. Revue Médicale Suisse, 9 (384) pp. 934-939. Peer-reviewed.
[Pmid][serval:BIB_817EBBDB2E4A]
 
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy.
Du Pasquier R.A., Jilek S., Kalubi M., Yerly S., Fux C.A., Gutmann C., Cusini A., Günthard H.F., Cavassini M., Vernazza P.L. et al., 2013. Aids, 27 (2) pp. 203-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53A5510C85E2]
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
Granziera C., Daducci A., Simioni S., Cavassini M., Roche A., Meskaldji D., Kober T., Metral M., Calmy A., Helms G. et al., 2013. Plos One, 8 (9) pp. e72547.
[URN][DOI][WoS][Pmid][serval:BIB_37E6E2376D1C]
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Jilek S., Schluep M., Pantaleo G., Du Pasquier R.A., 2013. Neurological Sciences, 34 (4) pp. 539-543.
[URN][DOI][WoS][Pmid][serval:BIB_4187CB3E957E]
 
Neurologie [2012: news in neurology].
Alvarez V., Rossetti A.O., Michel P., Kuntzer T., Nater B., Démonet J.F., Schluep M., Du Pasquier R., Vingerhoets F., 2013. Revue Médicale Suisse, 9 (368) pp. 62-65. Peer-reviewed.
[Pmid][serval:BIB_0DFA2D84055B]
 
On s'enflamme tous pour la tête [Head inflammation].
Du Pasquier R.A., Lalive P.H., 2013. Revue Médicale Suisse, 9 (384) p. 907.
[Pmid][serval:BIB_9E3E2897982B]
 
Reply to the letter of Zahednasab H. in Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
Du Pasquier R.A., Canales M., Schluep M., 2013. Neurology, 81 (1) p. 98. Peer-reviewed.
[WoS][Pmid][serval:BIB_36E58184B375]
 
Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study.
Simioni S., Cavassini M., Annoni J.M., Métral M., Iglesias K., Rimbault Abraham A., Jilek S., Calmy A., Müller H., Fayet-Mello A. et al., 2013. Neurology, 80 (6) pp. 553-560.
[DOI][WoS][Pmid][serval:BIB_D0BFAE403114]
 
Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].
Schluep M., Lalive P.H., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 940-943.
[Pmid][serval:BIB_8385AEC5E86A]
2012
 
Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control.
Schwab N., Ulzheimer J.C., Fox R.J., Schneider-Hohendorf T., Kieseier B.C., Monoranu C.M., Staugaitis S.M., Welch W., Jilek S., Du Pasquier R.A. et al., 2012. Neurology, 78 (7) pp. 458-467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B7DBDB2E020]
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital
Darling K.E., Hugli O., Mamin R., Cellerai C., Martenet S., Berney A., Peters S., Du Pasquier R.A., Bodenmann P., Cavassini M., 2012. Plos One, 7 (6) pp. e39299. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E065FD76F59C]
 
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Jilek S., Schluep M., Harari A., Canales M., Lysandropoulos A., Zekeridou A., Pantaleo G., Du Pasquier R.A., 2012. Journal of Immunology, 188 (9) pp. 4671-4680. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0D2159CC0F6]
 
Immunological and clinical consequences of treating a patient with natalizumab.
Schwab N., Höhn K.G., Schneider-Hohendorf T., Metz I., Stenner M.P., Jilek S., Du Pasquier R.A., Gold R., Meuth S.G., Ransohoff R.M. et al., 2012. Multiple Sclerosis, 18 (3) pp. 335-344. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41CCB1BCBDCD]
 
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Antoniol C., Jilek S., Schluep M., Mercier N., Canales M., Le Goff G., Campiche C., Pantaleo G., Du Pasquier R.A., 2012. Neurology, 79 (23) pp. 2258-2264.
[DOI][WoS][Pmid][serval:BIB_703F31D7E9A0]
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Simioni S., Schluep M., Bault N., Coricelli G., Kleeberg J., Du Pasquier R.A., Gschwind M., Vuilleumier P., Annoni J.M., 2012. Plos One, 7 (12) pp. e50718. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FE5B1827B7E7]
 
Neurologie [Neurology].
Chabwine J.N., Rossetti A.R., Hirt L., Kuntzer T., Schluep M., Michel P., Démonet J.F., du Pasquier R.A., Vingerhoets F.G., 2012. Revue Médicale Suisse, 8 (323) pp. 46-50. Peer-reviewed.
[Pmid][serval:BIB_2E4541BC9980]
 
Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia
Silva M., Chabwine J. N., Lhermitte B., Buss G., Maeder P., Du Pasquier R. A., 2012. p. 748 dans 16th Congress of the European-Federation-of-Neurological-Societies (EFNS), European Journal of Neurology.
[WoS][serval:BIB_F937C2D08CAB]
 
Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia.
Chabwine J.N., Lhermitte B., Da Silva M.O., Buss G., Maeder P., Du Pasquier R.A., 2012. Neurology, 78 (24) pp. 2000-2002.
[DOI][WoS][Pmid][serval:BIB_E1293A6E72CF]
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.
Stravodimou A., Cairoli A., Rausch T., Du Pasquier R., Michel P., 2012. Case Reports In Medicine, 2012 p. 239719.
[URN][DOI][Pmid][serval:BIB_AB92C502EDD1]
 
Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
Schluep M., Du Pasquier R., 2012. Revue Médicale Suisse, 8 (339) pp. 946-949.
[Pmid][serval:BIB_74AFB87DCACD]
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Ludigs K., Parfenov V., Du Pasquier R.A., Guarda G., 2012. Cellular and Molecular Life Sciences, 69 (20) pp. 3395-3418. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A93C669EA17D]
2011
 
Effect of vitamin D on EBV-specific CD8+T cells in patients with early multiple sclerosis
Lysandropoulos A., Schluep M., Jaquiery E., Jilek S., Canales M., Pantaleo G., Du Pasquier R., 2011. p. 117 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
[WoS][serval:BIB_8F68600C08F3]
 
Exploration of immune competencies of viral-specific CD8+T cells in MS patients using tetramers and functional CTL assays
Jilek S., Lysandropoulos A., Zekeridou A., Canales M., Schluep M., Pantaelo G., Du Pasquier R., 2011. p. 117 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
[WoS][serval:BIB_1BD948014659]
HIV-associated neurocognitive disorders (HAND): a changing pattern
Simioni S., Cavassini M., Annoni J.M., Hirschel B., Du Pasquier R.A., 2011. Future Neurology, 6 (1) pp. 81-95. Peer-reviewed.
[URN][DOI][serval:BIB_23BCBDFB8AF6]
 
Neurologie [Therapeutic advances in neurology].
Siclari F., Du Pasquier R.A., Schluep M., Michel P., Hirt L., Kuntzer T., Rossetti A.O., Ghika J., Nater B., Vingerhoets F.J., 2011. Revue Médicale Suisse, 7 (277) pp. 50-56. Peer-reviewed.
[Pmid][serval:BIB_90194C7612EC]
Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
Kuntzer T., Carota A., Novy J., Cavassini M., Du Pasquier R.A., 2011. Neurology, 76 (8) pp. 757-758. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_29B56BFBD556]
 
Type I interferon inhibits interleukin-1 production and inflammasome activation.
Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R.A., Romero P. et al., 2011. Immunity, 34 (2) pp. 213-223. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FCAE77ECF1C9]
 
Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
Lysandropoulos A.P., Jaquiéry E., Jilek S., Pantaleo G., Schluep M., Du Pasquier R.A., 2011. Journal of Neuroimmunology, 233 (1-2) pp. 240-244. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F1F4FF4D30A]
2010
 
A promenade along the stream of demyelination.
Du Pasquier R.A., 2010. Current Opinion In Neurology, 23 (3) pp. 203-204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B7C6E6B78C0]
 
Attaques cérébrovasculaires ischémiques multiples dues à une méningovasculite à Borrelia garinii. [Multiple ischemic strokes due to Borrelia garinii meningovasculitis].
Rey V., Du Pasquier R., Muehl A., Péter O., Michel P., 2010. Revue Neurologique, 166 (11) pp. 931-934. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_075630845790]
 
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
Simioni S., Cavassini M., Annoni J.M., Rimbault Abraham A., Bourquin I., Schiffer V., Calmy A., Chave J.P., Giacobini E., Hirschel B. et al., 2010. Aids, 24 (9) pp. 1243-1250. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53A019364BBB]
 
Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study.
Jaquiéry E., Jilek S., Schluep M., Le Goff G., Garcia M., Pantaleo G., Du Pasquier R.A., 2010. Journal of Neuroimmunology, 225 (1-2) pp. 167-170. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5972CAABD027]
 
Demyelination as a complication of new immunomodulatory treatments.
Lysandropoulos A.P., Du Pasquier R.A., 2010. Current Opinion In Neurology, 23 (3) pp. 226-233. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E58E112F7EF]
 
EFNS guidelines on diagnosis and management of neuromyelitis optica.
Sellner J., Boggild M., Clanet M., Hintzen R.Q., Illes Z., Montalban X., Du Pasquier R.A., Polman C.H., Sorensen P.S., Hemmer B., 2010. European Journal of Neurology, 17 (8) pp. 1019-1032. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_092371165802]
 
Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A. et al., 2010. Journal of Clinical Investigation, 120 (3) pp. 713-719. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F1CF4DFB5CB]
 
Imaging Properties of MS Lesions Correlate with Attention Deficits in Early Multiple Sclerosis
Simioni S., Kober T., Krueger G., Shevlyakova M., Browaeys P., Annoni J.M., Du Pasquier R., Meuli R., Schluep M., Granziera C., 2010. dans OHBM 2010, 16th Annual Meeting of the Organization for Human Brain Mapping.
[serval:BIB_28EBFD6DB1E8]
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Jilek S., Jaquiéry E., Hirsch H.H., Lysandropoulos A., Canales M., Guignard L., Schluep M., Pantaleo G., Du Pasquier R.A., 2010. Lancet Neurology, 9 (3) pp. 264-272. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C0A400887F2]
 
Intrathecal immune responses to EBV in early MS.
Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G., Du Pasquier R.A., 2010. European Journal of Immunology, 40 (3) pp. 878-887. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_64ADB928ABD6]
2009
 
Autoanticorps en neurologie: implications cliniques [Autoantibodies in neurological diseases: clinical implications]
Lalive P.H., Chofflon M., Du Pasquier R.A., Burkhard P.R., 2009. Revue Médicale Suisse, 5 (201) pp. 942-944, 946-948, 950.
[Pmid][serval:BIB_FA29E4C29502]
 
Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
Novy J., Carota A., Eggimann P., Pusztaszeri M., Rossetti A.O., Du Pasquier R., 2009. BMJ case reports, 2009 pp. 11 August. Peer-reviewed.
[DOI][Pmid][serval:BIB_BFAD9C19238A]
 
Encéphalites virales [Viral encephalitis: update]
Du Pasquier R., Meylan P., Kaiser L., Lalive P.H., 2009. Revue Médicale Suisse, 5 (201) pp. 968-970, 972-973.
[Pmid][serval:BIB_73C2B181EC4C]
 
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N., Wolbers M., Mueller N.J., Garzoni C., Du Pasquier R.A., Fux C.A., Vernazza P., Bernasconi E., Viscidi R., Battegay M. et al., 2009. Journal of Virology, 83 (9) pp. 4404-4411. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3F95551CBD5]
 
Neurologie [Therapeutic advances in neurology].
Morier J., Du Pasquier R., Kuntzer T., Michel P., Nater B., Niederhauser J., Rossetti A.O., Schluep M., Vingerhoets F., 2009. Revue Médicale Suisse, 5 (185) pp. 39-48. Peer-reviewed.
[Pmid][serval:BIB_C69F238127D7]
 
Nouveau spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapies [New spectrum of HIV-associated cognitive disorders in the HAART era]
Du Pasquier R., Cavassini M., Simioni S., Annoni J.M., Giacobini E., Hirschel B., 2009. Revue Médicale Suisse, 5 (201) pp. 955-956, 958-961.
[Pmid][serval:BIB_D5742DE8F1D4]
Progressive decline of decision-making performances during multiple sclerosis.
Simioni S., Ruffieux C., Kleeberg J., Bruggimann L., du Pasquier R.A., Annoni J.M., Schluep M., 2009. Journal of the International Neuropsychological Society, 15 (2) pp. 291-295. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_454F8ACC0454]
2008
Inaugural description of Cogan syndrome in an HIV-infected person.
Kleeberg J., Maire R., Chave J.P., Pournaras J.A., Guex-Crosier Y., Du Pasquier R.A., 2008. Journal of neurology, 255 (9) pp. 1427-8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AACDE7AC86FB]
 
Neurologie [Neurology]
Cereda C., Du Pasquier R., 2008. Revue Médicale Suisse, 4 (139) pp. 49-56.
[Pmid][serval:BIB_EDB3EBEE0079]
 
Neuropsychiatrie [Neuropsychiatry].
Burkhard P.R., Vingerhoets F.J., Landis T., Du Pasquier R.A., 2008. Revue Médicale Suisse, 4 (156) pp. 1131-1132.
[Pmid][serval:BIB_D26CA8487E0C]
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G., Du Pasquier R.A., 2008. Brain, 131 (Pt 7) pp. 1712-1721. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AF138C282868]
2007
 
Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.
Jilek S., Kuhle J., Meylan P., Reichhart M.D., Pantaleo G., Du Pasquier R.A., 2007/10. Journal of Neuroimmunology, 192 (1-2) pp. 192-197. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D78D489A8FDD]
 
Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids.
Deruaz C.A., Spertini F., Souza Lima F., Du Pasquier R.A., Schluep M., 2007. Multiple Sclerosis, 13 (4) pp. 559-560. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3BE273C5F85B]
 
Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
Yang W., Beaudoin E.L., Lu L., Du Pasquier R.A., Kuroda M.J., Willemsen R.A., Koralnik I.J., Junghans R.P., 2007. International Immunology, 19 (9) pp. 1083-1093. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF3BF6156A28]
 
CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Jilek S., Schluep M., Rossetti A.O., Guignard L., Le Goff G., Pantaleo G., Du Pasquier R.A., 2007. Clinical Immunology, 123 (1) pp. 105-113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5B9811DBA8DB]
 
Limbic encephalitis: another example of molecular mimicry?
Du Pasquier R., 2007. European Neurology, 57 (4) pp. 191-192. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DA21AC1F14C]
 
Neurologie [Neurology]
Botez S., Carota A., Dunand M., Du Pasquier R., Kuntzer T., Michel P., Morier J., Schluep M., Rossetti A.O., 2007. Revue Médicale Suisse, 3 (93) pp. 39-47. Peer-reviewed.
[Pmid][serval:BIB_4F16813D4FB5]
 
Neuromyelitis optica following CMV primo-infection.
Tran C., Du Pasquier R.A., Cavassini M., Guex-Crosier Y., Meuli R., Ciuffreda D., Waeber G., 2007. Journal of Internal Medicine, 261 (5) pp. 500-503. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13451DE0B788]
2006
 
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.
Vulliemoz S., Lurati-Ruiz F., Borruat F.X., Delavelle J., Koralnik I.J., Kuntzer T., Bogousslavsky J., Picard F., Landis T., Du Pasquier R.A., 2006/09. Journal of Neurology, 77 (9) pp. 1079-1082. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9E1DF7E3203]
 
Immunite et neurodegenerescence: nouveaux concepts dans la sclerose en plaques. [Immunity and neurodegeneration: new concepts in multiple sclerosis]
Lalive P. H., Schluep M., Chofflon M., Du Pasquier R., 2006/05. Revue Médicale Suisse, 2 (64) pp. 1166-8, 1170.
[Pmid][serval:BIB_FC2B4EEC7C13]
 
Functional signatures of protective antiviral T-cell immunity in human virus infections.
Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., Pantaleo G., 2006. Immunological Reviews, 211 pp. 236-254. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE2B6D903135]
 
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y., Trofe J., Gordon J., Du Pasquier R.A., Roy-Chaudhury P., Kuroda M.J., Woodle E.S., Khalili K., Koralnik I.J., 2006. Journal of Virology, 80 (7) pp. 3495-3505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A58C836C8B00]
 
JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients.
Du Pasquier R.A., Stein M.C., Lima M.A., Dang X., Jean-Jacques J., Zheng Y., Letvin N.L., Koralnik I.J., 2006. Journal of Neuroimmunology, 176 (1-2) pp. 181-186. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19E0B23452BA]
 
Neurologie. [Therapeutical advances in neurology in 2005]
Du Pasquier R., Bogousslavsky J., 2006/01. Revue Médicale Suisse, 2 (47) pp. 35-40.
[Pmid][serval:BIB_B2EC052008D4]
2005
 
Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
Du Pasquier R.A., Autissier P., Zheng Y., Jean-Jacques J., Koralnik I.J., 2005. Aids, 19 (18) pp. 2069-2076. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FC2634CA270]
 
Traitements immunomodulateurs/ suppresseurs en neurologie. [Immunomodulatory/suppressive treatments in neurology]
Schluep M., Chofflon M., Kuntzer T., Du Pasquier R., 2005. Revue Médicale Suisse, 1 (18) pp. 1229-1232. Peer-reviewed.
[Pmid][serval:BIB_E78B2022EA54]
2004
 
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., Koralnik I.J., 2004/09. Brain, 127 (Pt 9) pp. 1970-1978. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CA1196E3CA9]
 
Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.
Du Pasquier R.A., Schmitz J.E., Jean-Jacques J., Zheng Y., Gordon J., Khalili K., Letvin N.L., Koralnik I.J., 2004. Journal of Virology, 78 (18) pp. 10206-10210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_818367D60578]
 
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., Koralnik I.J., 2004. Neurology, 63 (5) pp. 897-900. Peer-reviewed.
[WoS][Pmid][serval:BIB_C8315E77A999]
2003
 
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual.
Du Pasquier R.A., Corey S., Margolin D.H., Williams K., Pfister L.A., De Girolami U., Mac Key J.J., Wüthrich C., Joseph J.T., Koralnik I.J., 2003/09. Neurology, 61 (6) pp. 775-782. Peer-reviewed.
[WoS][Pmid][serval:BIB_C7A6237D7315]
 
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.
Burkhard P.R., Delavelle J., Du Pasquier R., Spahr L., 2003. Archives of Neurology, 60 (4) pp. 521-528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AEAA0A0CC6F]
 
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?
Du Pasquier R.A., Koralnik I.J., 2003. Journal of Neurovirology, 9 (Suppl. 1) pp. 25-31. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_093532C3EED5]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University